Clinical trial vials

Glass vial used in clinical trials, containing experimental drug or placebo, under controlled temperature and light conditions.

About this subject

Vials used in clinical trials are critical components for study integrity and safety. Typically made from Type I borosilicate glass, these vials offer chemical and thermal resistance, protecting sensitive substances. They can be single-dose or multi-dose, depending on the protocol. In phase 3 trials, such as those for COVID-19 vaccines, millions of vials were distributed globally, many requiring cold chain storage between -70°C and 8°C. Labeling is standardized with alphanumeric codes to ensure blinding, preventing bias among patients and researchers. In Brazil, ANVISA requires that vials follow Good Manufacturing Practices (GMP) and full traceability, including batch number and expiration date. A curious detail: multi-dose vials contain preservatives to prevent bacterial contamination after first opening, while single-dose vials do not and are discarded immediately. The design also considers ease of handling by healthcare professionals, with rubber septa that allow multiple punctures without leakage. Glass transparency enables visual inspection for particles or color changes, indicating possible degradation.

Frequently Asked Questions

Why are clinical trial vials coded?

The codes ensure study blinding, preventing patients and researchers from knowing whether the content is the experimental drug or placebo. This avoids bias and ensures scientific validity of the results.

What is the difference between single-dose and multi-dose vials?

Single-dose vials contain only one dose and are discarded after use. Multi-dose vials contain preservatives and allow multiple withdrawals, often used for vaccines or to reduce waste.

How is traceability of vials ensured in clinical trials?

Each vial receives a batch number, expiration date, and a unique code recorded in electronic systems. This allows tracking from manufacturing to patient administration, as required by ANVISA and international regulatory agencies.